
GC63029
JAK1-IN-8
Also known as N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]-3-fluorophenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide
JAK1-IN-8, a potent JAK1 inhibitor (IC50<500 nM), compound 28, extracted from patent WO2016119700A1
ChemicalCAS1973485-18-5MW442.51FormulaC22H23FN4O3S
- CAS number
- 1973485-18-5
- Molecular weight
- 442.51
- Formula
- C22H23FN4O3S
- Solubility
- DMSO : 125 mg/mL (282·48 mM; Need ultrasonic)
- InChIKey
- QDYVZZJCRDVVQG-UHFFFAOYSA-N
- Catalogue number
- GC63029
- Brand
- GLPBIO
Computed properties PubChem CID 122462620 · XLogP 2.5 · TPSA 92.2 Ų · H-bond donors 1
- XLogP
- 2.5
- TPSA
- 92.2 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 31
SMILES C1CC1C(=O)NC2=CN3C(=N2)C=CC=C3C4=CC(=C(C=C4)CN5CCS(=O)(=O)CC5)F
Computed descriptors from PubChem (CID 122462620), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il